Board approved audited FY26 results with Rs 180 crore net profit and unmodified audit opinion.
Recommended final dividend of Rs 10 per share (500%) for financial year 2025-26.
Trading window for designated persons will reopen from May 8, 2026.
Company operates in single segment of specialty chemicals with no subsidiaries.